India at WHO-IRCH 2025: Leading the Global Traditional Medicine Agenda - A UPSC Analysis

 

India at WHO-IRCH 2025: Leading the Global Traditional Medicine Agenda - A UPSC Analysis

India's high-level participation in the 16th Annual Meeting of the WHO-IRCH in Jakarta underscores its strategic push to position its traditional systems of medicine (AYUSH) at the forefront of global healthcare. For a UPSC aspirant, this event is a significant case study in international relations, governance, and science & technology policy.

1. Core Facts (Prelims Focus)

• Event: 16th Annual Meeting of the WHO–International Regulatory Cooperation for Herbal Medicines (WHO-IRCH).

• Location: Jakarta, Indonesia.

• Key Indian Delegates:

  • Dr. Raghu Arackal, Advisor (Ayurveda), Ministry of Ayush (Head of Delegation).

  • Dr. Raman Mohan Singh, DDG (I/c), Ayush & Director, Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H).

  • Dr. Mahesh Dadhich, CEO, National Medicinal Plants Board (NMPB).

• Key Highlight: Release of Proceedings from the WHO-IRCH Workshop hosted by India in Ghaziabad (Aug 2025).

• Key Bilateral Agreement: Implementation of the MoU between PCIM&H (India) and the Indonesian FDA (signed Jan 26, 2025).

---

2.  Connecting the Dots for Mains

This development is highly relevant for GS Paper II (International Relations, Governance) and GS Paper III (Science & Tech, Environment).

GS Paper II: International Relations & Governance

• Topic: Bilateral, Regional and Global Groupings and Agreements involving India and/or affecting India’s interests.

  • Soft Power Diplomacy: India is leveraging its rich heritage in traditional medicine as a tool of soft power. By leading discussions on regulatory harmonization, India is exporting its knowledge systems and building long-term partnerships.

  • India-ASEAN Engagement: Strengthening ties with Indonesia, a key ASEAN nation, through an MoU on traditional medicine, fits into India's 'Act East Policy'. It moves beyond strategic ties to concrete cooperation in health and wellness.

  • Role of WHO & Global Health Governance: Active participation in WHO-IRCH allows India to help set global standards and regulations for herbal medicines. This ensures that Indian products face fewer trade barriers and gain wider international acceptance.

• Topic: Government Policies & Interventions for Development in various sectors

  • The entire initiative is a direct outcome of the government's policy to promote AYUSH systems. It demonstrates a strategic move from domestic promotion to global mainstreaming.

  • The establishment and active role of institutions like the PCIM&H and NMPB showcase a structured, institutional approach to governance in this sector.

GS Paper III: Science & Technology, Environment & Economy

• Topic: Awareness in the fields of IT, Space, Computers, robotics, nano-technology, bio-technology

  • The focus on "quality assurance," "technical expertise," and "Pharmacopoeia" highlights the scientific and evidence-based approach India is taking. It's about validating traditional knowledge with modern scientific parameters.

  • Issues relating to intellectual property rights (IPR): Harmonizing regulations helps in protecting India's traditional knowledge from biopiracy and ensures that benefits from products derived from Indian medicinal plants are shared fairly.

• Topic: Conservation, Environmental Pollution and Degradation

  • The role of the National Medicinal Plants Board (NMPB) is crucial here. International demand for standardized herbal medicines must be met with sustainable harvesting and cultivation of medicinal plants to prevent biodiversity loss. This links economic incentive with environmental conservation.

• Topic: Indian Economy

  • A globally accepted regulatory framework for AYUSH products opens up a massive export market for the Indian herbal industry, contributing to economic growth and creating jobs in cultivation, manufacturing, and research.

---

3.  Significance, Challenges & Way Forward (For Mains Answer Writing)

Significance of India's Participation:

1. Global Leadership in Traditional Medicine: This positions India as the "Vishwa Guru" (World Teacher) in traditional medicine, a domain where it has a comparative advantage.

2. Economic Opportunity: The global herbal market is worth hundreds of billions of dollars. Standardization is the key to unlocking this market for Indian companies.

3. Integrating with Modern Healthcare: It fosters the integration of traditional medicine with modern healthcare systems worldwide, promoting a more holistic approach to health.

4. Strengthening Domestic Ecosystem: International demand and collaboration will drive quality, research, and innovation within the domestic AYUSH sector.

Associated Challenges:

• Standardization and Quality Control: Ensuring consistent quality and bioactivity of plant-based products is complex due to variations in soil, climate, and processing methods.

• Scientific Validation: While India has a vast repository of traditional knowledge, converting it into evidence-based medicine through rigorous clinical trials (as per WHO norms) remains a challenge.

• Countering Pseudo-science: The global community is often skeptical. India's challenge is to champion traditional medicine while firmly distancing itself from unscientific claims.

• Sustainable Sourcing: Meeting global demand without leading to the over-exploitation and extinction of valuable medicinal plants is a critical concern.

Way Forward:

1. Boost R&D Investment: Increase funding for research in AYUSH to generate robust data on safety, efficacy, and mechanisms of action of herbal medicines.

2. Digital Traditional Knowledge Library (TKDL): Expand and proactively use the TKDL to prevent misappropriation of Indian traditional knowledge by foreign entities.

3. Skill Development: Train a new generation of professionals in ethnopharmacology, pharmacognosy, and regulatory affairs to support this sector.

4. Promote Cultivation: Through NMPB, incentivize the large-scale cultivation of medicinal plants to ensure a sustainable and quality-controlled supply chain.

---

4. Previous Year Questions (PYQ) Framework

Possible Prelims Question:

• The 'Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H)' functions under the administrative control of which of the following Ministries?
  (a) Ministry of Health and Family Welfare
  (b) Ministry of Science and Technology
  (c) Ministry of Ayush
  (d) Ministry of Commerce and Industry
  Answer: (c) Ministry of Ayush

Possible Mains Questions:

• GS Paper II: "India's traditional knowledge systems are a reservoir of soft power." Discuss this statement in the context of India's efforts to globalize AYUSH. (Use examples like the WHO-IRCH meeting, the establishment of the WHO Global Centre for Traditional Medicine in Jamnagar, and MoUs with various countries).

• GS Paper III: "Examine the potential of the AYUSH sector to contribute to India's economic growth and global leadership in healthcare." (Discuss the export potential, job creation, and the strategic importance of setting global standards).

• GS Paper II/III: "The harmonization of international regulations for herbal medicines presents both an opportunity and a challenge for India." Analyze. (Highlight the opportunity for market access and the challenge of meeting stringent quality and evidence standards).

Conclusion:

India's proactive role at the WHO-IRCH meeting is a strategic move that transcends health diplomacy. It is an effort to position the country at the helm of the emerging global paradigm of integrative and holistic health. For a UPSC aspirant, this represents a multifaceted issue involving international relations, economic strategy, scientific validation, and environmental sustainability, making it a potent topic for both Prelims and Mains.